A differentiation-inducing factor produced by the osteoblastic cell line MC3T3-E1 stimulates bone resorption by promoting osteoclast formation.
We have reported that the differentiation-inducing factor (DIF) is present in conditioned medium of mouse osteoblast-like cell (MC3T3-E1) cultures. In the present study, the DIF from conditioned medium of MC3T3-E1 cells was partially purified and its biologic activity was examined. The DIF was purified by monitoring the induction of phagocytic activity of mouse myeloblastic leukemia cells (M1). The DIF induced differentiation of not only M1 cells but also mouse myelomonocytic cells (WEHI-3). Furthermore, the DIF increased the in vitro bone-resorbing activity and the osteoclast number in mouse calvaria. The increases were inhibited by the addition of either salmon calcitonin or indomethacin. When mouse bone marrow cells were cultured with the DIF for 8 days, formation of osteoclast-like multinucleated cells was stimulated dose dependently. The DIF from MC3T3-E1 cells appeared to be different from interleukin-1 (IL-1), tumor necrosis factor (TNF), and transforming growth factor beta (TGF-beta). These results suggest that the DIF partially purified from osteoblast-like cell cultures stimulates osteoclastic bone resorption by promoting differentiation and fusion of osteoclast progenitors to form multinucleated osteoclasts.
Abe
E
E
Department of Biochemistry, School of Dentistry, Showa University, Tokyo, Japan.
Ishimi
Y
Y
Takahashi
N
N
Akatsu
T
T
Ozawa
H
H
Yamana
H
H
Yoshiki
S
S
Suda
T
T
D000818:Animals; D001685:Biological Factors / Q000096:biosynthesis / Q000494:pharmacology*; D001862:Bone Resorption / Q000187:drug effects*; D002116:Calcitonin / Q000494:pharmacology; D002460:Cell Line; D002848:Chromatography, DEAE-Cellulose; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D007335:Insulin-Like Growth Factor II; D007375:Interleukin-1 / Q000032:analysis; D007948:Leukemia, Monocytic, Acute / Q000378:metabolism; D008297:Male; D051379:Mice; D010006:Osteoblasts / Q000378:metabolism*; D010010:Osteoclasts / Q000187:drug effects*; D010587:Phagocytosis; D011506:Proteins / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D001685:Biological Factors; C035170:IGF2 protein, human; D007375:Interleukin-1; D011506:Proteins; D014409:Tumor Necrosis Factor-alpha; D007335:Insulin-Like Growth Factor II; C028815:salmon calcitonin; D002116:Calcitonin